Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Shares Outstanding (Weighted Average) (2016 - 2025)

Immucell (ICCC) has disclosed Shares Outstanding (Weighted Average) for 15 consecutive years, with $7.8 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Shares Outstanding (Weighted Average) rose 0.82% year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Jun 2024, up 0.82%, and an annual FY2023 reading of $7.7 million, changed 0.03% over the prior year.
  • Shares Outstanding (Weighted Average) was $7.8 million for Q2 2024 at Immucell, up from $7.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $7.8 million in Q2 2024 and bottomed at $7.2 million in Q1 2020.
  • Average Shares Outstanding (Weighted Average) over 5 years is $7.6 million, with a median of $7.7 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 28.24% in 2020, then rose 0.03% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $7.2 million in 2020, then increased by 5.25% to $7.6 million in 2021, then increased by 2.01% to $7.7 million in 2022, then increased by 0.03% to $7.7 million in 2023, then increased by 0.8% to $7.8 million in 2024.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ICCC at $7.8 million in Q2 2024, $7.7 million in Q4 2023, and $7.7 million in Q3 2023.